Leadership1 distinct publisher3 min readPublished
The transaction statistics that make revenue cycle management look automated only count exchanges that need no judgment, which is why a year of AI purchases left the same billers logging in to the same portals.
The Board Room · Leadership desk
Compiled by The Board RoomSomething wrong?How this is made
Follow any of these and your For You feed starts watching them — no settings page required.
leadership
Nobody ran an AI rollout at Buyers Edge. Its 1,200 employees did it themselves.1 distinct publisher
build
Pick the BAA, not the benchmark: where HIPAA document pipelines actually spend1 distinct publisher
leadership
Token Leaderboards Are The New Pageview Board, And Your Next Budget Will Fund Them1 distinct publisher
leadership
1,600 drones, 700 seizures: the World Cup air defence model does not scale1 distinct publisher
Electronic-transaction rates measure whether a standardized rail exists for an exchange and whether traffic used it. They do not measure whether a person had to decide something before the rail could carry anything. That is why CAQH can put eligibility at 96% electronic while prior authorization sits at 40% [2][3] without either figure being wrong: eligibility is a lookup, and prior authorization is a judgment with keystrokes attached. Attachments make the point harder, at 24% in medical spaces and declining [4], which leaves roughly three-quarters of that traffic with no standard transaction to ride [2]. Oleg Nesterov's summary of the pattern is that everything with a standard transaction gets automated and everything that requires deciding and then acting gets a work queue and a person to sit in it [5].
The distinction he draws is between coordination and execution: a coordination system tells a person what to do, an execution system does it, and by his account revenue cycle management has run the first for two decades while calling it the second [15]. Most RCM AI scores a denial by its likelihood of overturn and drafts the appeal, then routes the task back to a person to log in and finish [6]. Staff still open as many as 11 portals a day [7], and a single fully electronic prior authorization can mean eligibility in one portal, submission in a second, status in a third and documentation in an EHR connected to none of them, which he estimates at 10 minutes or more of manual work [8].
The two MGMA readings are the closest thing here to a labor measurement, and they need handling. Sixty-eight percent of medical groups added or expanded AI tools in 2025 [9]; in a different poll with a different set of 260 respondents, 68% said AI had not led them to redesign a single role or change staffing [10]. Those are separate populations, so the pairing is directional rather than a before-and-after. What makes it credible anyway is the mechanism: a tool that ends by handing work to a biller cannot remove the biller, and the 60% of prior authorizations that are not fully electronic [1] are precisely the work that ends that way.
The diagnosis is convenient for its source: Nesterov's firm builds AI agents and custom software for US revenue cycle management [1], and a market that bought advice and still needs action is a market for what he sells. Two points hold up regardless. His load-bearing figures come from CAQH, MGMA and HFMA rather than his own book [2][9][12], and his criteria are concrete enough for a buyer who does not trust him to test: holding credentials through two-factor prompts and session timeouts, which he calls the unglamorous 80% of the job; reading remittances, denial letters and payer policy PDFs that are often scanned; and authority to correct, resubmit or write off under rules that change monthly [13]. The material contains no case of a system meeting those criteria reducing billing headcount, so on labor cost the honest answer is that we do not know yet.
So the choice this quarter is narrower than the category pitch. Most groups have already bought something [9]; what remains open is whether the next renewal is scored on completed actions rather than accurate recommendations, because a tool that terminates in a work queue commits the practice to staffing that queue for as long as it owns the tool. On the other side, a payer engine returns a decision in seconds and the provider answers with a person opening a portal, reading the reason and assembling the appeal by hand [14]. That asymmetry compounds on a monthly cycle, not a decade-long one.
Ranked by verification strength, evidence, and original report placement.
Oleg Nesterov is the founder and CEO of MindK, which builds AI agents and custom software for U.S. healthcare revenue cycle management.
Eligibility runs 96% electronically by CAQH's count.
Attachments sit at 24% in medical spaces and are falling.
According to MGMA, 68% of medical groups reported adding or expanding AI tools in 2025.
In another MGMA poll with a different set of 260 respondents, 68% said AI had not led them to redesign a single role or change staffing.
Distinct publishers with included, body-backed reporting in this cluster.
forbes.com
1 article · September 1, 2026
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Institutional numbers, one interested narrator
Every figure that carries this story — CAQH's 96% eligibility and 40% prior authorization, MGMA's twin 68% readings, HFMA's 65% of denials never reworked — is genuine industry research, and none of it reaches us directly. It arrives through a vendor CEO's retelling in Forbes, without links, editions or methodology, and the two MGMA polls are different respondent pools by the piece's own admission. The claims that need verifying most, about what most 'agentic' tools actually do, have no citation at all.
Bought broadly, executing nowhere visible
The adoption picture in this reporting cuts against the product it recommends. Purchase is documented — 68% of medical groups expanded AI last year — and outcome is documented as absent, with 68% of a separate sample reporting no role or staffing change. Autonomous execution, the thing the essay says the market needs, has no evidence of use whatsoever: no practice named, no login count before and after, no denial-recovery figure, not even from MindK, which sells the category.
Deflates the slide deck, inflates the sequel
An unusual shape. Most of the essay punctures 'autonomous back office' marketing, and that half is the best-evidenced writing in it — the survey pair and the unworked-denial figure do real work. Then it defines a four-bullet execution layer that happens to describe its author's business and offers nothing to show such a system logs in, places a call to a payer, or removes a single seat. Scepticism measured; remedy asserted.
The diagnosis names the product
Nesterov's firm builds exactly the portal-logging, payer-calling agents the essay says the market lacks, and the buyer's test he proposes — count removed logins, check the org chart — is one his category passes and coordination tools fail by construction. Forbes' own footer identifies the venue as an invitation-only executive council, and no payer, EHR vendor, or tool accused of merely recommending gets a line in reply.
One desk, one voice, no counterparty
We are holding a well-argued hypothesis, not a finding. A single publisher, a single interested author, and the sharpest specifics — that a fully electronic prior authorization still burns ten minutes, that staff hit eleven or more portals a day — rest on what he says he has seen. The scaffolding is checkable in principle: MGMA and CAQH publish, and nobody in this coverage went and read them.